Table 1.

Baseline characteristics of randomized patients

	P-3051 (n = 60)	Amorolfine 5% (n = 60)
	Age, years	51.45±11.75	53.85±12.21
Gender
Male	6 (10.0)	10 (16.7)
Female	54 (90.0)	50 (83.3)
Caucasian	60 (100)	60 (100)
Weight, kg	71.80±12.70	73.20±10.30
Fungal species
Dermatophytes	43 (71.7)	47 (78.3)
Yeast	12 (20.0)	11 (18.3)
Nondermatophyte moulds	5 (8.3)	2 (3.4)
Number of toenails with clinical
evidence of onychomycosis	6.8±2.0	7.5±2.0
Percentage of infected target
nail area	44.62 ±12.93	46.20±13.58

Data are the mean ± SD, or n (%).